Market News AIOpen the app

DERM stock news · Journey Medical Corporation

Stories about Journey Medical Corporation (DERM) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for DERM

Follow Journey Medical Corporation (DERM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for DERM
Free on the App Store and Google Play, or on the web.
  1. Nov 12, 2026, 4:11 PM ET · Market

    Journey Medical Corp shared its third-quarter results, showing $19.0 million in total sales and a big jump in Emrosi® sales.

    Good for DERM

    Journey Medical's third-quarter sales rose 8% to $19.0 million, while Emrosi sales rose 84% to $9.0 million. Its smaller loss and product margin rising from 67% to 69% make this favorable.